• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [25062 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2022     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Palliative care day centre service offer for users and caregivers]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palliation vs. curation - an attempt to clarify terms]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Palivizumab for the prevention of respiratory syncytial virus lower respiratory tract infections]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - Benefit assessment according to § 35a SGB V]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - Addendum to Commission A18-63]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - Addendum to commission A16-74]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer, combination with an aromatase inhibitor) - Addendum to Commission A22-66]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Pain school - a health technology assessment]
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [Pain relief effects of injection therapy for patients with chronic back pain]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pain in endometriosis: do other procedures instead of painkillers also help?]
2011     Andalusian Health Technology Assessment Area (AETSA) [Paediatric triage systems in hospital emergency department: reliability and validity]
2019     Canary Health Service [PACS system and its possible application in the management of NO-DICOM clinical objects]
2006     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Paclitaxel-Eluting Coronary Stent System in cardiovascular treatment; systematic review of the clinical and economic literature]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Paclitaxel-coated balloon dilatation in recurrent bulbar urethral strictures]
2011     Finnish Office for Health Care Technology Assessment (Finohta) [Paclitaxel-coated balloon angioplasty in the treatment of coronary artery disease and peripheral artery stenosis – a systematic review]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [P16/Ki-67 dual stain in the triage of PAPIII/IIID cytology in cervical cancer screening]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Ozone therapy]
2006     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Ozone therapy in the treatment of herniated disc and other painful conditions of the lumbar]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Ozone therapy for the treatment of lumbar disc disease]
2006     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Ozone therapy for the treatment of intervertebral herniated disk]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Ozone therapy for the treatment of dental caries]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ozanimod (ulcerative colitis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ozanimod (relapsing remitting multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ozanimod (multiple sclerosis) - Addendum to Commission A20-59]
2010     Andalusian Health Technology Assessment Area (AETSA) [Oxygen carriers. Production of red blood cells from human embryonic stem cells]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Overweight prevention in adolescents and children (behavioural and environmental prevention]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Overweight prevention in adolescents and children (behavioural and environmental prevention]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Overweight in the teenager population: quality of life, access to health care services and cost-effectiveness of interventions]
2013     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Overweight and obesity: the efficacy of diets for weight maintenance after weight loss]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of the use of antihypertensive agents by adults covered by the Québec public prescription drug insurance plan]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of the drugs used by children and adolescents diagnosed with autism spectrum disorder who are covered by the Public Prescription Drug Insurance Plan]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of service use to address the medical needs of seniors receiving home care]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of dabigatran usage among people insured by the public prescription drug insurance plan]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of applications of extended reality technologies in health and social services]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview – Quebec frequent emergency department users 2022-2023]
2022     Norwegian Institute of Public Health (NIPH) [Overdose warning systems: a single technology assessment - mapping]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Over-, under- and misuse of pain treatment in Germany]
2023     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Ovarian tissue cryopreservation and transplantation in patients with cancer or benign diseases to fertility preservation]
2008     Haute Autorite de sante (HAS) [Ovarian drilling by laparoscopy or transvaginal fertiloscopy]
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Outpatient pulmonary rehabilitation - rehabilitation models and shortcomings in outpatient aftercare]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation. part V: study protocol, multi-centre prospective controlled observational study with two parallel groups on outpatient cardiac phase III rehabilitation]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation part VII: Economic Evaluation]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III)]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation Part 4: Options for carrying out a prospective study]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation Part 3b: Retrospective cohort study (with/without phase III rehabilitation) - application of the evaluation plan]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation Part 3a: Retrospective cohort study (with/without phase III rehabilitation) - explorative analysis and developing of an evaluation plan]
2011     National Evidence-based Healthcare Collaborating Agency (NECA) [Outcomes research of preventive procedures in unruptured intracranial aneurysm]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Outcomes research for complications of inhaled bronchodilators/corticosteroids]
2007     Andalusian Health Technology Assessment Area (AETSA) [Outcomes of treatments for stuttering]
2008     Andalusian Health Technology Assessment Area (AETSA) [Outcomes of transanal endoscopic surgery in patients with rectal tumours]
2008     Andalusian Health Technology Assessment Area (AETSA) [Outcomes of transanal endoscopic surgery in patients with rectal tumours]
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [Outcomes of therapeutic modalities for post-partum hemorrhage]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Outcomes beyond health]
1994     Basque Office for Health Technology Assessment (OSTEBA) [Osteoporosis therapy in the Basque Country]
2010     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osteodensitometry in primary and secondary osteoporosis]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ospemifene - benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib: benefit assessment according to §35a Social Code Book V]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Osimertinib in lung cancer]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (NSCLC) - Benefit assessment according to §35a Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (NSCLC) - Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (NSCLC, combination with pemetrexed and platinum-based chemotherapy) – benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (NSCLC, combination with pemetrexed and platinum-based chemotherapy) – Addendum to Project A24-77]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (NSCLC, adjuvant) – benefit assessment according to §35a Social Code Book V]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (lung cancer) - Addendum to Commission A17-20]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (locally advanced, unresectable NSCLC) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (locally advanced, unresectable NSCLC) – Addendum to Project A25-03]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osilodrostat (endogenous Cushing syndrome) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Orlistat for weight loss in overweight or obese patients]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Organizational and economic issues in the management of patients with acute ST-segment elevation myocardial infarction (STEMI)]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organizational alternatives for anesthesia in cataract surgery]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of stroke care services]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of care and services for stroke to optimize access to endovascular treatment in Quebec]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization and provision of rehabilitation services for stroke patients and their families: a review of the evidence]
2024     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Organisational structures of Canadian knowledge transfer or mobilization groups serving research in university hospitals and health technology assessment]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in palliative care. A comparison on consumption of resources]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in caring type 2 diabetes mellitus patients. Literature review and economic assessment]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in caring for patients with cancer]
2012     Canary Health Service [Organisational models in cancer pain management]
2018     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Organisational models for securing access to health and dental care services for children in out-of-home care]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Oral health with fixed appliances orthodontics]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Oral health with fixed appliances orthodontics]
1997     Finnish Office for Health Care Technology Assessment (Finohta) [Oral health care technology]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Optimizing diagnosis of recurrent events using (almost) continuous monitoring ancillary study of costs and effects of strategies to prevent oversedation in intensive care patients, nr 80-007022-98-04103]
2007     The Netherlands Organisation for Health Research and Development (ZonMw) [Optimization of the reach of the Liberman modules 'symptom management' and 'medication management']
2007     The Netherlands Organisation for Health Research and Development (ZonMw) [Optimization of diagnostic imaging use in patients with acute abdominal pain: cost-effectiveness analysis of imaging strategies]
2007     The Netherlands Organisation for Health Research and Development (ZonMw) [Optimising circulating blood volume after subarachnoid haemorrhage]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in hematology]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in clinical immunology]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guidelines for the pharmacological treatment of Alzheimer's disease and mixed dementia]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: herpes simplex eye disease]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: blepharitis]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: antibiotic prophylaxis during clean orthopedic surgery in children and adults]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal usage guide: cellulitis in adults and children]
2024     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Optimal observation period after an electrical cardioversion under sedation]